![Andriy Mushak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andriy Mushak
Director of Finance/CFO at
TELOMIR PHARMACEUTICALS, INC.
Profile
Andriy Mushak began working as Chief Financial Officer at Telomir Pharmaceuticals, Inc. in 2026 and continues in this role.
In the same year, Mr. Mushak also started as Chief Financial Officer at MIRA Pharmaceuticals, Inc. and remains in this position.
Andriy Mushak active positions
| Companies | Position | Start |
|---|---|---|
| TELOMIR PHARMACEUTICALS, INC. | Director of Finance/CFO | 06/06/2026 |
| MIRA PHARMACEUTICALS, INC. | Director of Finance/CFO | 06/06/2026 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
MIRA Pharmaceuticals, Inc.
 MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
Telomir Pharmaceuticals, Inc.
 Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
- Stock Market
- Insiders
- Andriy Mushak
